The agreement grants ALK exclusive global rights to the neffy ® adrenaline (epinephrine) nasal spray, with exception of the USA, Australia, New Zealand, Japan and China. The deal delivers on key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback